Therapeutic Dilemmas in Young Patients with Early Stage Endometrial Cancer
نویسندگان
چکیده
Editorial Nowadays, endometrial cancer (EC) is the 2nd most common tumor of the female reproductive system and the 5th most common cancer among female patients [1,2]. It is more frequent in wealthy and more developed countries (Northern and Western Europe, Northern America), while the mortality rate is considerably greater in less developed ones (Northern Africa, Melanesia)[1,2]. Despite the fact that the vast majority of EC patients are postmenopausal, approximately 14% of them are premenopausal and almost 4% are below 40 years of age [319]. It is widely believed that conservative management of those young patients with EC, represents a great challenge [3-19].
منابع مشابه
حفظ باروری در زنان جوان مبتلا به کانسر آندومتر، گزارش سه بیمار
Background: Although endometrial cancer is primarily a disease of the postmenopausal female, 25% of patients are premenopausal, with 3-5% in women 40 years old or younger. The younger group of women with endometrial carcinoma are frequently nulligravid with a history of infertility, and a strong desire to preserve fertility. This may pose a therapeutic dilemma for both patients and treating phy...
متن کاملO-29: Fertility Sparing Treatments in Young Patients with Gynecological Cancers: A Large Iranian Experience and A Literature Review
Background: The marriage age has been increasing recently throughout the world and researches have shown an increased rate of gynecological cancers among young women. Therefore, fertility sparing in these patients is an important point and many works have been done on conservative management in young women with gynecological cancer. Materials and Methods: In this study, we report our experience...
متن کاملI-29: Fertility Preservation in Early, Low Grade Endometrial Cancer
Background Endometrial cancer is the most common gynecologic malignancy in the United States, with over 40,000 cases diagnosed each year, typically in the postmenopausal women. 25% of cases affect premenopausal women. 14% of endometrial cancers are diagnosed in women younger than 45 years old. 5% of these tumors are diagnosed in women younger than 40 years old. In this talk the learning objecti...
متن کاملنقش گیرنده‌های هورمونی استروژن و پروژسترون در درمان کنسرواتیو آدنوکارسینوم خوب تمایزیافته اندومتر مرحله Ia با مژسترول استات
Background: Surgery is the most effective treatment of well-differentiated endometrial cancer. But using systemic progestins, have been evaluated to treat the young patients with well-differentiated endometrial cancer who wish to preserve their fertility. The aim of this study was the evaluation of megestrol acetate on endometrial adenocarcino-ma with regard to the receptors. Methods: This was...
متن کاملPrevalence of endometrial cancer in young patients
Background: Cancer of the endometrium is the most common gynecologic malignancy in western and industrial countries, and is the second most common in developing countries, therefore it is of special importance. Adenocarcinoma of the endometrium is the most common type of uterine cancer. The prevalence of endometrial cancer in young women under the age of 40 in western country is very low and ab...
متن کامل